Valuation: Brooks Laboratories Limited

Market Cap 1.86B 19.37M 16.78M 15.87M 14.37M 26.96M 27.17M 189M 72.86M 942M 72.77M 71.16M 3.01B P/E 2025
-28.6x
P/E 2026 4.45x
Enterprise Value 1.88B 19.57M 16.95M 16.03M 14.51M 27.23M 27.44M 191M 73.58M 952M 73.5M 71.87M 3.04B EV / Sales 2025
3.93x
EV / Sales 2026 1.3x
Free-Float
44.12%
Yield 2025 *
-
Yield 2026 -
08-13 Brooks Laboratories Limited Reports Earnings Results for the First Quarter Ended June 30, 2026 CI
07-17 Brooks Laboratories Limited Announces Appointment of Rajesh Mahajan to President Trading and Senior Management Personnel, Effective July 17, 2026 CI
06-19 Steriscience Specialties Private Limited agreed to acquire an additional 16.33% stake in Brooks Steriscience Limited from Brooks Laboratories Limited for INR 1.1 billion. CI
05-29 Brooks Laboratories appoints Prashant Rathi as CEO RE
05-29 Brooks Laboratories names Prashant Rathi as CEO RE
05-29 Brooks Laboratories Limited Announces Appointment of Prashant Rathi as Chief Executive Officer, Effective June 1, 2026 CI
05-29 Brooks Laboratories Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2026 CI
02-06 Brooks Laboratories Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2025 CI
16/10/25 Brooks Laboratories Limited Announces That Mr. Rajesh Mahajan Resigned as President - Procurement, with Effect from 16 October 2025 CI
13/08/25 Brooks Laboratories Limited Reports Earnings Results for the First Quarter Ended June 30, 2025 CI
28/05/25 Brooks Laboratories Limited Reports Earnings Results for the Full Year Ended March 31, 2025 CI
13/02/25 Brooks Laboratories Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2024 CI
26/12/24 Brooks Laboratories Limited Appoints Ms. Krutika Mohan Rane as Company Secretary & Compliance Officer, Effective 26 December 2024 CI
1 day-3.87%
1 week-3.28%
Current month-7.86%
1 month+1.32%
3 months-8.43%
6 months+9.46%
Current year-23.30%
1 week 59.68
Extreme 59.68
69.01
1 month 58.26
Extreme 58.26
71.35
Current year 36.9
Extreme 36.9
82.3
1 year 36.9
Extreme 36.9
156.5
3 years 36.9
Extreme 36.9
202.8
5 years 36.9
Extreme 36.9
202.8
10 years 14.05
Extreme 14.05
202.8
Manager TitleAgeSince
Chief Executive Officer 58 23/01/2002
Chief Executive Officer - 01/06/2026
President 57 23/08/2023
Director TitleAgeSince
Director/Board Member 53 23/11/2022
Director/Board Member 62 10/09/2010
Director/Board Member - 23/08/2023
Change 5-day change 1-year change 3-year change Capi.($)
-3.87%-3.28% - - 19.37M
+0.64%-0.99%+14.65%+60.89% 45.9B
-4.55%-6.60%+28.67%+95.78% 38.7B
+0.78%-1.76%+7.07%+72.15% 11.43B
+0.64%-0.26%-12.80%+9.59% 11.38B
-0.95%0.00%+19.82%+146.45% 9.09B
-0.39%+0.40%+27.64%+36.47% 7.3B
+1.79%-0.81%+16.28%+183.62% 6.98B
-1.00%-0.98%+33.68%-20.38% 7.13B
-2.15%-4.76%-44.26%+4.59% 4.89B
Average -0.90%-2.24%+10.08%+65.46% 15.86B
Weighted average by Cap. -1.04%-2.68%+15.66%+71.37%

Financials

2025 2026
Net sales 826M 8.61M 7.45M 7.05M 6.38M 11.98M 12.07M 84.12M 32.36M 419M 32.33M 31.61M 1.34B 857M 8.94M 7.74M 7.32M 6.63M 12.44M 12.53M 87.36M 33.61M 435M 33.57M 32.83M 1.39B
Net income -99.67M -1.04M -900K -851K -770K -1.45M -1.46M -10.16M -3.91M -50.54M -3.9M -3.82M -161M 246M 2.56M 2.22M 2.1M 1.9M 3.57M 3.59M 25.05M 9.64M 125M 9.63M 9.41M 398M
Net Debt 75.39M 786K 681K 644K 583K 1.09M 1.1M 7.68M 2.96M 38.23M 2.95M 2.89M 122M 18.44M 192K 166K 157K 143K 268K 270K 1.88M 723K 9.35M 722K 706K 29.82M
Logo Brooks Laboratories Limited
Brooks Laboratories Limited is an India-based pharmaceutical manufacturing company. The Company specializes in supplying pharmaceutical products to government bodies, healthcare institutions, and large organizations. It operates through two segments, which include manufacturing and trading. The manufacturing segment comprises its own manufacturing operations and loan-licensing business relating to pharmaceutical products, ingredients, and intermediaries. The trading segment comprises principal-to-principal trading activities in pharmaceutical products, ingredients, and intermediaries. Its General Products offerings include Liquid Injection (Ampoules), Liquid Injection (Vials), Dry Powder Injections (Vials), Lyophilised Injections, Eye/Ear Drops, and Nasal Drops. The Company's Critical Care Division (CCD), operates through a robust distribution network, delivering injectables to hospitals and healthcare institutions across India.
Employees
347
Date Price Change Volume
16/09/26 61.55 -3.87% 2,222
15/09/26 ₹64.03 -3.35% 4,128
11/09/26 ₹66.25 +4.22% 6,842
10/09/26 ₹63.57 -0.11% 1,990
09/09/26 ₹63.64 -0.50% 4,101
LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!